Genedata Forges Alliance with Intellicyt
News Jun 18, 2015
The firms will integrate Genedata's Screener software with IntelliCyt's iQue Screener system.
The alliance will bring Genedata's highly-scalable data analytics to IntelliCyt's high-throughput flow cytometry capabilities. The iQue Screener can analyze more than 10,000 cells or beads per second, the firm said in a statement, an order of magnitude increase over plate-based systems, with up to 15 parameters per cell.
"Advanced computational analysis solutions are required to handle the quantity and complexity of data obtained in high-throughput flow cytometry experiments in large-scale screening applications," Janette Phi, chief business officer at Albuquerque, New Mexico-based IntelliCyt, said in a statement. "The combined solution of Genedata Screener software and the IntelliCyt iQue Screener platform addresses this unmet industry need. Our solution provides a powerful option for our customers for robust and accurate data analysis across all plates from high-throughput flow cytometry data generated by iQue."
The combined technologies will enable researchers to screen large libraries of drug candidates against suspension cells and multiplex beads in phenotypic drug discovery, antibody screening, immunology, and biomarker research, the firms said.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug CandidateNews
Researchers have discovered that synthetic APC-mimicking small molecules called “parmodulins” provide anti-inflammatory and anti-thrombotic protection to endothelial cells on par with APC’s without interfering with normal blood clotting and coagulation, making them attractive new drug candidates.READ MORE
Brian Berridge Set to Manage National Toxicology ProgramNews
The National Toxicology Program (NTP) has named Brian Berridge, D.V.M., Ph.D., as its new Associate Director. Berridge, formerly of GlaxoSmithKline, will oversee day-to-day operations as NTP coordinates toxicology research and testing across nine different federal agencies.READ MORE